| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Finch Therapeutics Group Inc (NASDAQ: FNCH)
FNCH Technical Analysis
5
| As on 9th Jun 2023 FNCH STOCK Price closed @ 0.27 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.10 & Strong Sell for SHORT-TERM with Stoploss of 8.86 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FNCHSTOCK Price
| Open | 0.27 | Change | Price | % |
| High | 0.28 | 1 Day | -0.01 | -3.57 |
| Low | 0.26 | 1 Week | -0.01 | -3.57 |
| Close | 0.27 | 1 Month | -0.17 | -38.64 |
| Volume | 539035 | 1 Year | -8.68 | -96.98 |
| 52 Week High 10.79 | 52 Week Low 0.27 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FNCH Daily Charts |
FNCH Intraday Charts |
Whats New @ Bazaartrend |
FNCH Free Analysis |
|
|
FNCH Important Levels Intraday
| RESISTANCE | 0.31 |
| RESISTANCE | 0.30 |
| RESISTANCE | 0.29 |
| RESISTANCE | 0.28 |
| SUPPORT | 0.26 |
| SUPPORT | 0.25 |
| SUPPORT | 0.24 |
| SUPPORT | 0.23 |
FNCH Forecast May 2024
| 4th UP Forecast | 5.78 |
| 3rd UP Forecast | 4.01 |
| 2nd UP Forecast | 2.92 |
| 1st UP Forecast | 1.83 |
| 1st DOWN Forecast | -1.29 |
| 2nd DOWN Forecast | -2.38 |
| 3rd DOWN Forecast | -3.47 |
| 4th DOWN Forecast | -5.24 |
FNCH Weekly Forecast
| 4th UP Forecast | 4.10 |
| 3rd UP Forecast | 2.87 |
| 2nd UP Forecast | 2.11 |
| 1st UP Forecast | 1.35 |
| 1st DOWN Forecast | -0.81 |
| 2nd DOWN Forecast | -1.57 |
| 3rd DOWN Forecast | -2.33 |
| 4th DOWN Forecast | -3.56 |
FNCH Forecast2024
| 4th UP Forecast | 21.29 |
| 3rd UP Forecast | 14.55 |
| 2nd UP Forecast | 10.38 |
| 1st UP Forecast | 6.22 |
| 1st DOWN Forecast | -5.68 |
| 2nd DOWN Forecast | -9.84 |
| 3rd DOWN Forecast | -14.01 |
| 4th DOWN Forecast | -20.75 |
Finch Therapeutics Group Inc ( NASDAQ USA Symbol : FNCH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FNCH Business Profile
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that has completed Phase II clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and FIN-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and crohn's disease. The company has collaboration and license agreements with Millennium Pharmaceuticals, Inc.; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts. Address: 200 Inner Belt Road, Somerville, MA, United States, 02143
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service